X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Pfizer with Lupin Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs LUPIN LTD - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

LUPIN LTD 
   Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER LUPIN LTD PFIZER/
LUPIN LTD
 
P/E (TTM) x 31.2 20.1 155.2% View Chart
P/BV x 5.0 2.7 182.2% View Chart
Dividend Yield % 0.7 0.9 71.0%  

Financials

 PFIZER   LUPIN LTD
EQUITY SHARE DATA
    PFIZER
Mar-16
LUPIN LTD
Mar-17
PFIZER/
LUPIN LTD
5-Yr Chart
Click to enlarge
High Rs2,7241,750 155.7%   
Low Rs1,6111,384 116.4%   
Sales per share (Unadj.) Rs440.9387.4 113.8%  
Earnings per share (Unadj.) Rs48.756.6 86.0%  
Cash flow per share (Unadj.) Rs75.876.8 98.6%  
Dividends per share (Unadj.) Rs15.007.50 200.0%  
Dividend yield (eoy) %0.70.5 144.6%  
Book value per share (Unadj.) Rs462.9298.9 154.9%  
Shares outstanding (eoy) m45.75451.58 10.1%   
Bonus/Rights/Conversions -ESOPS-  
Price / Sales ratio x4.94.0 121.6%   
Avg P/E ratio x44.527.7 160.9%  
P/CF ratio (eoy) x28.620.4 140.3%  
Price / Book Value ratio x4.75.2 89.3%  
Dividend payout %30.813.2 232.6%   
Avg Mkt Cap Rs m99,163707,513 14.0%   
No. of employees `0002.916.8 17.2%   
Total wages/salary Rs m2,75828,495 9.7%   
Avg. sales/employee Rs Th6,981.710,418.3 67.0%   
Avg. wages/employee Rs Th954.51,697.0 56.2%   
Avg. net profit/employee Rs Th771.11,523.0 50.6%   
INCOME DATA
Net Sales Rs m20,170174,943 11.5%  
Other income Rs m8571,065 80.5%   
Total revenues Rs m21,028176,008 11.9%   
Gross profit Rs m4,31044,931 9.6%  
Depreciation Rs m1,2399,122 13.6%   
Interest Rs m51,525 0.3%   
Profit before tax Rs m3,92335,349 11.1%   
Minority Interest Rs m0-72 0.0%   
Prior Period Items Rs m083 0.0%   
Extraordinary Inc (Exp) Rs m990-   
Tax Rs m1,7949,785 18.3%   
Profit after tax Rs m2,22825,575 8.7%  
Gross profit margin %21.425.7 83.2%  
Effective tax rate %45.727.7 165.2%   
Net profit margin %11.014.6 75.6%  
BALANCE SHEET DATA
Current assets Rs m16,299119,542 13.6%   
Current liabilities Rs m7,59461,206 12.4%   
Net working cap to sales %43.233.3 129.4%  
Current ratio x2.12.0 109.9%  
Inventory Days Days6576 85.9%  
Debtors Days Days2690 28.7%  
Net fixed assets Rs m8,622131,660 6.5%   
Share capital Rs m458903 50.7%   
"Free" reserves Rs m20,722134,073 15.5%   
Net worth Rs m21,180134,976 15.7%   
Long term debt Rs m2556,478 0.0%   
Total assets Rs m29,137266,073 11.0%  
Interest coverage x755.524.2 3,125.0%   
Debt to equity ratio x00.4 0.3%  
Sales to assets ratio x0.70.7 105.3%   
Return on assets %7.710.2 75.2%  
Return on equity %10.518.9 55.5%  
Return on capital %19.019.3 98.6%  
Exports to sales %0.10-   
Imports to sales %17.50-   
Exports (fob) Rs m12NA-   
Imports (cif) Rs m3,526NA-   
Fx inflow Rs m5281,885 0.1%   
Fx outflow Rs m14021,506 0.7%   
Net fx Rs m-8860,378 -0.1%   
CASH FLOW
From Operations Rs m3,43641,148 8.4%  
From Investments Rs m-6,991-25,287 27.6%  
From Financial Activity Rs m-6194,332 -14.3%  
Net Cashflow Rs m-4,17420,193 -20.7%  

Share Holding

Indian Promoters % 0.0 46.6 -  
Foreign collaborators % 63.9 0.2 31,950.0%  
Indian inst/Mut Fund % 7.5 11.3 66.4%  
FIIs % 4.9 31.9 15.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 10.1 234.7%  
Shareholders   85,207 98,259 86.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   PLETHICO PHARMA  DIVIS LABORATORIES  FULFORD INDIA  ALKEM LABORATORIES  AJANTA PHARMA  

Compare PFIZER With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes Marginally Lower; Capital Goods & Realty Stocks Fall(Closing)

Indian share markets witnessed selling pressure in the final hour of trade to finish just below the dotted line. At the closing bell, the BSE Sensex closed lower by 71 points.

Related Views on News

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Feb 20, 2018 (Close)

TRACK PFIZER

PFIZER - FULFORD INDIA COMPARISON

COMPARE PFIZER WITH

MARKET STATS